Vaccine News and Research

Latest Vaccine News and Research

Multiplex proteomic panel assay for assessment of disease severity and outcome prediction in COVID-19

According to the authors of a new study, multiplex protein panel assay could support clinical decision-making, guide the development of novel treatments, and expand the risk assessment procedures for COVID-19.

7 Dec 2021

Homologous mRNA and heterologous vaccines elicit high immune responses

New study findings show that homologous mRNA or heterologous vaccination induces the highest immune responses due to high RBD- and S1-specific antibodies.

7 Dec 2021

Impact of infection control measures and vaccines in protecting healthcare workers from COVID-19

New study findings highlight the importance of COVID-19 vaccination in reducing the risk of infection among healthcare workers.

7 Dec 2021

Study analyzes which factors play a role when people decide for or against vaccination

Getting vaccinated against Covid-19 can play a crucial role in ending the pandemic. But too many people are rejecting the vaccination. In a large online survey in May 2021, a team from the psychology department at Ruhr-Universität Bochum (RUB) analyzed which factors play a role when people decide for or against vaccination.

7 Dec 2021

Possible impact of spike protein mutations on SARS-CoV-2 Omicron variant

The current study not only analyses the mutations in the Omicron spike variant but classifies various combinations of spike mutations into groups.

7 Dec 2021

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

A new study indicates an immunological response to SARS-CoV-2 vaccines in immunosuppressed patients that were comparable to healthy patients.

7 Dec 2021

Immune response of Pfizer vaccinees who received Moderna or Pfizer booster

A new preprint discusses the immune boost resulting from homologous or heterologous booster doses in individuals fully vaccinated with two doses of the Pfizer vaccine.

7 Dec 2021

Data science proved what Pittsburgh’s Black leaders knew: Racial disparities compound covid risk

The ferocity of the covid-19 pandemic did what Black Pittsburgh — communities that make up a quarter of the city's population — thought impossible. It shook the norms.

7 Dec 2021

When the surges just keep coming: A view from the covid vortex

Dr. Rais Vohra has impeccable timing. He stepped into his role as interim health officer of Fresno County just months before the start of the covid-19 pandemic.

7 Dec 2021

Comparison of waning COVID-19 immunity between vaccinated and infected individuals

The current study compares the waning of immunity in infected-and-recovered vs. vaccinated cohorts.

7 Dec 2021

Risk factors for COVID-19 among US healthcare workers

Researchers from the CDC have investigated the risk posed to healthcare workers and which factors are most likely to lead to infection.

7 Dec 2021

Study finds mRNA-based COVID-19 vaccines are effective in cancer patients

The mRNA-based COVID-19 vaccines are effective at preventing infection in most cancer patients, according to a nationwide study of veterans diagnosed with cancer in the past decade.

6 Dec 2021

Scientists develop and characterize variant-specific vaccines against SARS-CoV-2

In a recent study conducted at Yale University, USA, scientists have investigated the immunogenicity of mRNA-based coronavirus disease 2019 (COVID-19) vaccine candidates encoding the spike proteins of different severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants. The findings reveal that the vaccines induce robust immune responses against SARS-CoV-2 variants. The study is currently available on the bioRxiv* preprint server.

6 Dec 2021

Omicron variant increases risk of SARS-CoV-2 reinfection

New surveillance data from South Africa published in the medRxiv* preprint server suggests that the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omnicron variant has the potential to escape naturally-acquired immunity. The research indicates people who previously recovered from a coronavirus disease 2019 (COVID-19) are at risk for reinfection with the Omicron variant. The results show that the risk of reinfection is greater with the Omicron variant versus Delta and Beta.

6 Dec 2021

Martin Kemp appears as Father Christmas in a new film to increase COVID-19 vaccine uptake

Former soap star and member of Spandau Ballet Martin Kemp has joined the national effort to get people vaccinated - by appearing as Father Christmas in a new film released today (Tuesday 7 December).

6 Dec 2021

SARS-CoV-2 S2 immunization as a pan-coronavirus vaccine approach

A new mouse model suggests that prior HCoV-OC43 S immunity primes neutralising antibody responses to otherwise subimmunogenic SARS-CoV-2 S exposure as well as promotes S2-targeting antibody responses.

6 Dec 2021

Study shows COVID booster shots work

A new study investigates uses seven different COVID-19 vaccines as the third dose to boost immunity in vulnerable patients.

6 Dec 2021

SARS-CoV-2 Delta saliva viral load 15 times that of the wild type

Researchers hypothesize that a higher viral load of SARS-CoV-2 Delta variant in saliva contributes to its high transmissibility.

6 Dec 2021

SARS-CoV-2 virus-like particles elicit potent neutralizing antibody response in variant challenge

Researchers develop a virus-like particle for SARS-CoV-2 based on the co-expression of the spike, membrane, and envelope structural proteins.

6 Dec 2021

Most young people improve quickly from COVID-19 vaccine-related myocarditis

Most young people under the age of 21 who developed suspected COVID-19 vaccine-related heart muscle inflammation known as myocarditis had mild symptoms that improved quickly, according to new research published today in the American Heart Association's flagship journal Circulation.

6 Dec 2021